These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16384636)

  • 1. Oligodendrocyte/myelin injury and repair as a function of the central nervous system environment.
    Antel J
    Clin Neurol Neurosurg; 2006 Mar; 108(3):245-9. PubMed ID: 16384636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis and central nervous system demyelination.
    Pouly S; Antel JP
    J Autoimmun; 1999 Nov; 13(3):297-306. PubMed ID: 10550217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia and multiple sclerosis.
    Jack C; Ruffini F; Bar-Or A; Antel JP
    J Neurosci Res; 2005 Aug; 81(3):363-73. PubMed ID: 15948188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: a battle between destruction and repair.
    McQualter JL; Bernard CC
    J Neurochem; 2007 Jan; 100(2):295-306. PubMed ID: 17101032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
    Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
    Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of multiple sclerosis.
    Agrawal SM; Yong VW
    Int Rev Neurobiol; 2007; 79():99-126. PubMed ID: 17531839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N; Swaab DF; Hoek RM; Huitinga I
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is damage in central nervous system due to inflammation?
    Chavarria A; Alcocer-Varela J
    Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice.
    Leder C; Schwab N; Ip CW; Kroner A; Nave KA; Dornmair K; Martini R; Wiendl H
    Mol Cell Neurosci; 2007 Nov; 36(3):416-24. PubMed ID: 17889554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD; McMahon EJ; Schreiner B; Bailey SL
    Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
    Raine CS; Scheinberg L; Waltz JM
    Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histo-clinical variation in multiple sclerosis: Heterogeneous proteolytic immunogenic processing.
    Westall FC
    Med Hypotheses; 2006; 66(3):566-9. PubMed ID: 16236458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease.
    Butts BD; Houde C; Mehmet H
    Cell Death Differ; 2008 Jul; 15(7):1178-86. PubMed ID: 18483490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
    Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immune responses in central nervous system inflammation.
    Finsen B; Owens T
    FEBS Lett; 2011 Dec; 585(23):3806-12. PubMed ID: 21624366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis and basis for treatment in multiple sclerosis.
    Compston A
    Clin Neurol Neurosurg; 2004 Jun; 106(3):246-8. PubMed ID: 15177777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.